Isolevuglandins, oxidatively truncated phospholipids, and atherosclerosis - Wikidata - awgldk - TriplyDB

Isolevuglandins, oxidatively truncated phospholipids, and atherosclerosis

Isolevuglandins, oxidatively truncated phospholipids, and atherosclerosis

http://www.wikidata.org/entity/Q28263158

about

sameAs

Generation and biological activities of oxidized phospholipids Oxidative lipidomics coming of age: advances in analysis of oxidized phospholipids in physiology and pathology Polyoxygenated cholesterol ester hydroperoxide activates TLR4 and SYK dependent signaling in macrophages.The role of oxidized phospholipids in atherosclerosis.GRP78 is a novel receptor initiating a vascular barrier protective response to oxidized phospholipids MD-2 binds cholesterol.Endothelial cell regulation by phospholipid oxidation products.Isolevuglandins covalently modify phosphatidylethanolamines in vivo: detection and quantitative analysis of hydroxylactam adducts.Advances in methods for the determination of biologically relevant lipid peroxidation products.Lysophosphatidic acid effects on atherosclerosis and thrombosis.An inter-laboratory validation of methods of lipid peroxidation measurement in UVA-treated human plasma samples.Protein targets of oxidized phospholipids in endothelial cells.Total Synthesis Confirms the Molecular Structure Proposed for Oxidized Levuglandin D2.Phospholipid hydroxyalkenals, a subset of recently discovered endogenous CD36 ligands, spontaneously generate novel furan-containing phospholipids lacking CD36 binding activity in vivo.

P2860

Q28389691-113FF678-83B1-4828-BFB0-1D8E069803AE Q28397441-43C471AD-8E39-4018-8641-141DF599A06E Q28537901-0E7B82E9-75A1-4175-8065-4E3F2300DD97 Q30436606-1474CDBA-F0DE-4A08-B9AC-1CC796F431F6 Q33811945-2E95FAE5-F7BF-4654-AE7D-EF2DF49237BF Q37025111-ED495F14-9D0F-4D63-B372-01E63D491965 Q37156030-67CD39F8-9E76-45DA-987D-D9071B7BCF98 Q37438010-87181B69-C02A-4E73-A079-07ADF43313FB Q37788232-C76D1A9C-718B-41B7-9791-C23AC108DD99 Q39608397-AC8BDA7B-4FA4-4C39-A295-64EA0361509D Q42909162-30494BAE-81AB-48B7-B116-47FFBBE792CD Q46491468-8AAE5A03-C06C-4460-8139-C719431FE6A7 Q48239770-CC535D4F-3D01-4A07-B19E-6AD890DC84D4 Q48447481-B1739524-9E90-48BF-99F5-5E879D67F421

P2860

Isolevuglandins, oxidatively truncated phospholipids, and atherosclerosis

http://www.wikidata.org/entity/Q28263158

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

name

Isolevuglandins, oxidatively truncated phospholipids, and atherosclerosis

@ast

Isolevuglandins, oxidatively truncated phospholipids, and atherosclerosis

@en

Isolevuglandins, oxidatively truncated phospholipids, and atherosclerosis

@nl

type

label

Isolevuglandins, oxidatively truncated phospholipids, and atherosclerosis

@ast

Isolevuglandins, oxidatively truncated phospholipids, and atherosclerosis

@en

Isolevuglandins, oxidatively truncated phospholipids, and atherosclerosis

@nl

altLabel

Isolevuglandins, Oxidatively Truncated Phospholipids, and Atherosclerosis

@en

prefLabel

Isolevuglandins, oxidatively truncated phospholipids, and atherosclerosis

@ast

Isolevuglandins, oxidatively truncated phospholipids, and atherosclerosis

@en

Isolevuglandins, oxidatively truncated phospholipids, and atherosclerosis

@nl

P1433

Q28263158-54224B24-FE41-4257-9DAA-9A26F0AEB6B3

P1476

Q28263158-6437B040-B0B0-4C49-8E5F-1F8F974683D1

Q28263158-EC1976F5-2615-49CC-A4AB-1F4BD4444197

P2093

Q28263158-5D23C2B0-8597-4353-BCD8-173262CF9254

Q28263158-884DB141-D8BA-48CB-A2B3-8D1EC0E3E073

P2860

Q28263158-1519D9E4-C6FE-4E40-991F-E7D4D475DB8C

Q28263158-1A476CD3-DFFA-4F0A-B506-6388BF17C3F2

Q28263158-1F8C1470-2249-449D-98BD-E5CE07967728

Q28263158-2079735A-DC48-48A7-A238-9A94F0186D29

Q28263158-2F96D394-8792-4A20-B9C1-4B8F8339D79E

Q28263158-302BB836-2667-44ED-9365-CDC8910CC91A

Q28263158-32903509-27D8-4270-96FE-83C660F623C7

Q28263158-3D8E37ED-C0FC-4763-8CE1-E7DE37A2B558

Q28263158-66EF8145-8CDA-4D34-9B29-AEC15322EBA5

Q28263158-8F420F68-0578-4288-BE99-40D0C18F2FA2

P304

Q28263158-20595AD0-E7DA-4579-B688-61C0418765F0

Q28263158-3CE48B9A-1EA5-451C-94D1-7E521D865ED4

P31

Q28263158-0A2A21D0-D201-4DD6-998F-BB2D01263F95

P356

Q28263158-F2606515-DBBD-4F0D-BCF7-F3A1549E0A78

P407

Q28263158-A9D726DB-B428-48C3-ADA0-CB597D8A75A4

P433

Q28263158-963E3B89-FABF-4BBB-903E-E264C7ECBD73

P478

Q28263158-F688F8E2-F42E-4B75-B290-EF7C1ADDD188

P577

Q28263158-DFC69A98-6609-4699-A655-D6937CBA527C

P698

Q28263158-C9C15C2E-188A-4075-A522-00F2125AA4E6

P921

Q28263158-E0941D37-5A11-4D3D-8D5E-FAD0693FDA73

P356

ANNALS.1333.040

P1433

Annals of the New York Academy of Sciences

P1476

Isolevuglandins, Oxidatively Truncated Phospholipids, and Atherosclerosis

@en

Isolevuglandins, oxidatively truncated phospholipids, and atherosclerosis

@en

P2093

ROBERT G. SALOMON

http://www.w3.org/2001/XMLSchema#string

Robert G Salomon

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of the lysyl adducts formed from prostaglandin H2 via the levuglandin pathway

Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

Inactivation of lysosomal proteases by oxidized low density lipoprotein is partially responsible for its poor degradation by mouse peritoneal macrophages

Distinguishing levuglandins produced through the cyclooxygenase and isoprostane pathways.

Extraction and partial characterization of dialysable products originating from the peroxidation of liver microsomal lipids and inhibiting microsomal glucose 6-phosphatase activity.

Formation of DNA-protein cross-links in mammalian cells by levuglandin E2.

A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions.

Hydroxy alkenal phospholipids regulate inflammatory functions of endothelial cells.

Phospholipid hydroxyalkenals: biological and chemical properties of specific oxidized lipids present in atherosclerotic lesions.

P304

327-342

http://www.w3.org/2001/XMLSchema#string

327-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1196/ANNALS.1333.040

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1043

http://www.w3.org/2001/XMLSchema#string

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16037255

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis